Fiasp
Drug
Novo Nordisk Inc
Total Payments
$198,214
Transactions
27
Doctors
19
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $204.98 | 10 | 10 |
| 2023 | $124,780 | 7 | 4 |
| 2022 | $65,328 | 9 | 4 |
| 2019 | $7,900 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $189,154 | 7 | 95.4% |
| Consulting Fee | $8,675 | 2 | 4.4% |
| Food and Beverage | $288.17 | 15 | 0.1% |
| Education | $96.81 | 3 | 0.0% |
Payments by Type
Research
$189,154
7 transactions
General
$9,060
20 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Comparison of post-prandial glycemic control in non-critically ill hospitalized patients with type 2 | Novo Nordisk Inc | $189,154 | 0 |
Top Doctors Receiving Payments for Fiasp
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $189,154 | 7 |
| , M.D | Endocrinology, Diabetes & Metabolism | San Diego, CA | $7,900 | 1 |
| , MD | Neurological Surgery | Great Neck, NY | $775.00 | 1 |
| , APRN | Adult Health | Salt Lake City, UT | $64.54 | 2 |
| , MD | Internal Medicine | Blackfoot, ID | $32.27 | 1 |
| , MD | Internal Medicine | Allison Park, PA | $24.97 | 1 |
| , MD | Internal Medicine | Allison Park, PA | $24.97 | 1 |
| , M.D | Preventive Medicine/Occupational Environmental Medicine | Canton, GA | $22.17 | 1 |
| , FNP-C | Family | Canton, GA | $22.17 | 1 |
| , PA-C | Physician Assistant | Canton, GA | $22.17 | 1 |
| , PA-C | Family Medicine | Canton, GA | $22.17 | 1 |
| , MD | Family Medicine | Canton, GA | $22.17 | 1 |
| , PA-C | Physician Assistant | Tampa, FL | $19.65 | 1 |
| , M.D | Family Medicine | Tampa, FL | $19.65 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Chicago, IL | $18.97 | 1 |
| , M.D | Internal Medicine | Milton, MA | $18.97 | 1 |
| , MD | Internal Medicine | Milford, CT | $16.07 | 1 |
| , M.D | Surgery | El Paso, TX | $15.43 | 1 |
| , MD | Internal Medicine | Gainesville, FL | $12.39 | 1 |
| , D.O | Internal Medicine | Pine Grove, PA | $6.25 | 1 |
Ad
Manufacturing Companies
- Novo Nordisk Inc $197,439
- Novo Nordisk AS $775.00
Product Information
- Type Drug
- Total Payments $198,214
- Total Doctors 19
- Transactions 27
About Fiasp
Fiasp is a drug associated with $198,214 in payments to 19 healthcare providers, recorded across 27 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk Inc.
Payment data is available from 2019 to 2024. In 2024, $204.98 was paid across 10 transactions to 10 doctors.
The most common payment nature for Fiasp is "Unspecified" ($189,154, 95.4% of total).
Fiasp is associated with 1 research study, including "Comparison of post-prandial glycemic control in non-critically ill hospitalized patients with type 2" ($189,154).